However, with the advent of PSMA-based imaging, we are now able to detect previously undetectable cases of OMPC, with PSMA PET/CT now being considered the most accurate diagnostic imaging modality for detecting oligometastasis in prostate cancer patients [54, 55]. This evidence concerns the gene FOLH1 and prostate carcinoma.